Inflammatory arthritis, spondyloarthritis and monitoring
Inflammatory arthritis assessment integrates symptom duration, joint distribution, objective swelling, stiffness, function and extra-articular findings. Persistent small-joint synovitis can support rheumatoid arthritis, but infection, crystal disease, psoriasis-associated disease and other explanations remain relevant. Classification criteria organize defined research populations and may assist thinking; they are not a substitute for clinical diagnosis or a rule that treatment must wait until every threshold is reached.
Rheumatoid arthritis can affect more than joints. Nodules, lung disease, neuropathy, vasculitic features and hematological abnormalities require appropriate assessment. Monitoring should consider inflammation, function, treatment adverse effects and comorbid risks. A low composite score can conceal an important organ problem or residual activity. Treat-to-target involves shared goals, repeated assessment and suitable treatment adjustment, not automatic escalation based on one isolated laboratory result.
Spondyloarthritis encompasses axial and peripheral manifestations with variable combinations of inflammatory back symptoms, enthesitis, dactylitis, psoriasis, uveitis and inflammatory bowel disease. HLA-B27 is an association, not a diagnostic test with universal predictive value. Imaging findings must fit the clinical context; marrow edema alone is not exclusive to inflammatory disease. Distinguish a structural classification feature from evidence of currently active inflammation.
Disease-modifying treatments have different mechanisms and risk profiles. Methotrexate, costimulation modulation, cytokine blockade and targeted small molecules are not interchangeable. Baseline infection screening, appropriate laboratory review, reproductive planning, comorbid disease and patient preference affect selection. Current recommendations and actual medicine information govern decisions. An international approval or a trial result does not automatically establish Egyptian availability or national first-line policy.
Consider the person’s movement, work, self-care and fatigue alongside disease control. Rehabilitation can include suitable exercise, joint protection, adaptations and education, coordinated with medical management. New fever, acute hot-joint symptoms, severe neurological findings or new cardiopulmonary compromise need urgent assessment rather than attribution to a routine flare. Written practice cannot reproduce a complete joint examination, imaging interpretation, prescribing assessment or supervised specialist training.